Boston, MA, United States of America

Georgios Trichonas

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Massachusetts Eye and Ear Infirmary. Active years: 2016-2020.

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Georgios Trichonas in Ocular Health

Introduction

Georgios Trichonas is a notable inventor based in Boston, MA, who has made significant contributions to the field of ocular health. With a total of three patents to his name, his work focuses on preserving the viability of photoreceptor cells and retinal pigment epithelial cells in individuals suffering from various ocular disorders.

Latest Patents

Trichonas's latest patents include innovative compositions aimed at preserving photoreceptor cells and retinal pigment epithelial cells. These compositions are particularly relevant for patients with age-related macular degeneration (AMD), retinitis pigmentosa (RP), or retinal detachment. The methods involve administering a necrosis inhibitor, either alone or in combination with an apoptosis inhibitor, to maintain cell viability. This approach minimizes the loss of vision or visual function associated with these ocular conditions.

Career Highlights

Georgios Trichonas is affiliated with the Massachusetts Eye and Ear Infirmary, where he continues to advance research in ocular health. His work has garnered attention for its potential to improve the quality of life for individuals affected by serious eye disorders.

Collaborations

Trichonas collaborates with esteemed colleagues such as Demetrios Vavvas and Joan W. Miller, contributing to a rich environment of innovation and research in the field of ophthalmology.

Conclusion

Georgios Trichonas's contributions to ocular health through his patents and research are paving the way for new treatments that could significantly enhance visual function for those with ocular disorders. His work exemplifies the impact of innovation in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…